Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discovery to late-phase clinical development BOSTON, MA – Invicro, LLC, a leading provider of imaging services and software for research and drug development, announced today the acquisition of UK-based Imanova. Invicro and Imanova will merge all activities to establish the world’s largest provider of translational […]
Genedata pioneers the use of artificial intelligence for classifying high content images Basel, Switzerland – Genedata, a leading provider of advanced software solutions for R&D, today launched its Early Access Program to Deep Learning for High Content Screening (HCS) image analysis. The proprietary and trailblazing software will enable pharmaceutical R&D organizations to reduce the time it takes […]
Synomics Studio enables scientists to perform massive association studies correlating up to 50 genomic, phenotypic and clinical factors with disease risk and therapy response Oxford, United Kingdom -September 6th, 2017- Complex data analytics software provider RowAnalytics Ltd today announced the release of Synomics Studio, its powerful new multi-SNP association platform for large scale genomic population studies. Synomics […]
Cambridge, UK — Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre (CHUC). Through this partnership, the hospital has licensed Congenica’s Sapientia™ software platform to perform analysis of whole-exome sequencing data and […]
Oxford Nanopore has released a new basecaller, Albacore v2.0.1, that identifies DNA sequences directly from raw data, rather than utilising an intermediary stage called ‘event detection’. This upgrade enhances accuracy of the single-read sequence data, contributing to high consensus accuracy for nanopore sequence data. Moving to raw basecalling also opens up opportunities for further improvements […]
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced changes in its senior management structure. Walt Woltosz, chairman and chief executive officer of Simulations Plus, Inc., said, “The board of directors has appointed Mr. John DiBella president of the Lancaster, California division, known as […]
DNAnexus has teamed up with Saphetor, a leading variant analysis company, to build a sample-in, report-out genomic analysis solution. Saphetor annotates and classifies genetic variants from next-generation sequencing (NGS) data to help clinicians quickly and accurately diagnose disease to make faster, more precise treatment decisions. Saphetor’s technology is now available on the DNAnexus cloud-based platform. Saphetor has […]
Major update incorporates new models and tighter integration with GastroPlus™ Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, chemicals, and consumer goods industries, today announced that it has released version 2 of its in vitro data analysis program, MembranePlus™. John DiBella, vice president for marketing and sales for Simulations Plus, said: […]
BOSTON, Mass., and PHILADELPHIA, Penn., August 15, 2017 – Seven Bridges, the biomedical data analysis company, today announced that it has been selected to build a new data center in partnership with the Center for Data Driven Discovery in Biomedicine (D³b) at the Children’s Hospital of Philadelphia and a consortium of academic research institutions. This effort is funded by […]
Significant update of liver safety program includes performance and capability enhancements DILIsym Services Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that it has released Version 6A of its flagship QSP (quantitative systems pharmacology) modeling program, DILIsym. Dr. Paul Watkins, chair of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
